A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
Clinical trial NCT07104162 · RECRUITING
Trial details
- NCT number
- NCT07104162
- Sponsor
- Qpex Biopharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2026-07-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.